Answers are grounded in this paper and cite their sources.
Editorial on the Research TopicAdvances in mast cell physiology and mast cell-driven diseases Mast cells (MCs) are long-lived tissue-resident immune cells occupying their final residence in several locations, including the fetal liver during fetal development.In adults, they arise from bone marrow-derived progenitors, which, after a short passage in the blood, migrate to their final destination and differentiate into mature MCs (1).They are predominant in tissues that are in close contact with the external environment, such as the skin or at mucosal surfaces, but can be found in virtually every organ, often increasing during an inflammatory process (2).They are well-known effectors of IgE-mediated immune responses protecting against parasitic infections and toxins such as snake venoms but are also key effectors of allergies.When activated through IgE receptors (FceRI), they release a whole set of inflammatory mediators stored in cytoplasmic granules, including histamine and various MC-specific proteases (3).This is followed by a wave of newly synthesized lipid mediators, such as prostaglandins and leukotrienes, and a large variety of chemokines and cytokines, thereby perpetuating and regulating the initiated inflammatory response.Besides FceRI, MCs express a large set of other receptors (4) empowering them to respond to IgE-independent stimuli in various physiological settings, implicating them as contributors to IgE-independent autoimmune diseases, various chronic inflammatory disorders, and cancers including mastocytosis.A recently described receptor, MRPRX2, has received great attention due to its ability to interact with a large variety of positively charged chemical compound and peptides, being responsible for the development of so-called pseudo-allergic reactions as well as the crosstalk with the peripheral nervous system, releasing neuropeptides (5).This Research Topic assembles 10 original research articles and one review article with a large majority (five) devoted to the recently discovered MC-specific receptor MRGPRX2.Two articles analyze MCs in the context of transformation and mastocytosis, and the remaining articles seek to further characterize and describe the physiology/ pathophysiology of MCs in different contexts.Concerning the study of MRGPRX2, Thapaliya et al. investigate the effect of various inhibitors of G protein-coupled receptor
No takes yet. Share an insight, caveat, or question.
Blank et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: